Close
The page header's logo
Help
Login
Staff Login
Register
FR
0
Selected 
Invert selection
Deselect all
Deselect all
 Add to Cart
 Click here to refresh results
 Click here to refresh results
Go to Login page
 Hide details
doctype icon
Conceptually similar
Feds defend not donating Pfizer, Moderna vaccines to poor countries
play button
CP126934421 | Feds defend not donating Pfizer, Moderna vaccines to poor countries 
Manitoba approves different second dose after AstraZeneca COVID-19 vaccine
play button
CP124342421 | Manitoba approves different second dose after AstraZeneca COVID-19 vaccine 
N.S. pauses use of AstraZeneca vaccine
play button
CP123262421 | N.S. pauses use of AstraZeneca vaccine 
Delaying second COVID-19 vaccine dose could pose procurement issues: Anand
play button
CP114691210 | Delaying second COVID-19 vaccine dose could pose procurement issues: Anand 
Newsroom Ready: Feds defend not donating Pfizer, Moderna vaccines to poor countries
play button
CP126935221 | Newsroom Ready: Feds defend not donating Pfizer, Moderna vaccines to poor countries 
Ontario to resume AstraZeneca shots for COVID-19 as second dose
play button
CP123774871 | Ontario to resume AstraZeneca shots for COVID-19 as second dose 
B.C. to delay second dose of COVID-19 vaccine to four months
play button
CP119239521 | B.C. to delay second dose of COVID-19 vaccine to four months 
AstraZeneca recipients can get Moderna or Pfizer for second dose: NACI
play button
CP124397371 | AstraZeneca recipients can get Moderna or Pfizer for second dose: NACI 
Vaccine panel says Pfizer, Moderna are 'preferred' as second doses
play button
CP125287571 | Vaccine panel says Pfizer, Moderna are 'preferred' as second doses 
Second-dose choice likely for AstraZeneca recipients: Tam
play button
CP123597771 | Second-dose choice likely for AstraZeneca recipients: Tam 
Action button
Placeline/People
City Vaughan
Country Canada

Nearly one million COVID-19 vaccine doses arriving in Canada this week: Anand

Procurement Minister Anita Anand says 500,000 doses of the Oxford-AstraZeneca vaccine produced by the Serum Institute of India are on their way to Canada. About 445,000 more from Pfizer-BioNTech will arrive this week. 
Actions
 Add to collection
 Add to cart
Information
Source name: 
The Canadian Press
Unique identifier: CP119321831 
Legacy Identifier: n_COVID-Cda20210302T1525 
Type: Video 
Duration: 2m4s 
Dimensions: 1920px Ă— 1080px     143.75 MB 
Usage rights: FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE. 
Create Date: 3/2/2021 3:25:00 PM 
Display aspect ratio: 16:9 
Tags
COVID-19
Covishield
health care
healthcare policy
india
Oxford-AstraZeneca
SHIPMENT
vaccine
vaccines